RATIONALE: The airflow limitation that defines severity of chronic obstructive pulmonary disease (COPD) is caused by a combination of small airway obstruction and emphysematous lung destruction. OBJECTIVES: To examine the hypothesis that small airway obstructive and emphysematous destructive lesions are produced by differential expression of genes associated with tissue repair. METHODS: The expression of 54 genes associated with repair of repetitively damaged tissue was measured in 136 paired samples of small bronchioles and surrounding lung tissue separated by laser capture microdissection. These samples were collected from 63 patients at different levels of disease severity who required surgery for either lung cancer or lung transplantation for very severe COPD. Gene expression was measured by quantitative polymerase chain reaction in these paired samples and compared with the FEV(1) by linear regression analysis. MEASUREMENTS AND MAIN RESULTS: After corrections for false discovery rates, only 2 of 10 genes (serpin peptidase inhibitor/plasminogen activator inhibitor member 2 and matrix metalloproteinase [MMP] 10) increased, whereas 8 (MMP2, integrin-alpha1, vascular endothelial growth factor, a disintegrin and metallopeptidase domain 33, scatter factor/hepatocyte growth factor, tissue inhibitor of matrix metalloproteinase-2, fibronectin, and collagen 3alpha1) decreased in small airways in association with FEV(1). In contrast, 8/12 genes (early growth response factor 1, MMP1, MMP9, MMP10, plasminogen activator urokinase, plasminogen activator urokinase receptor, tumor necrosis factor, and IL13) increased and 4/12 (MMP2, tissue inhibitor of matrix metalloproteinase-1, collagen 1alpha1, and transforming growth factor-beta3) decreased in the surrounding lung tissue in association with progression of COPD. CONCLUSIONS: The progression of COPD is associated with the differential expression of a cluster of genes that favor the degradation of the tissue surrounding the small conducting airways.
RATIONALE: The airflow limitation that defines severity of chronic obstructive pulmonary disease (COPD) is caused by a combination of small airway obstruction and emphysematous lung destruction. OBJECTIVES: To examine the hypothesis that small airway obstructive and emphysematous destructive lesions are produced by differential expression of genes associated with tissue repair. METHODS: The expression of 54 genes associated with repair of repetitively damaged tissue was measured in 136 paired samples of small bronchioles and surrounding lung tissue separated by laser capture microdissection. These samples were collected from 63 patients at different levels of disease severity who required surgery for either lung cancer or lung transplantation for very severe COPD. Gene expression was measured by quantitative polymerase chain reaction in these paired samples and compared with the FEV(1) by linear regression analysis. MEASUREMENTS AND MAIN RESULTS: After corrections for false discovery rates, only 2 of 10 genes (serpin peptidase inhibitor/plasminogen activator inhibitor member 2 and matrix metalloproteinase [MMP] 10) increased, whereas 8 (MMP2, integrin-alpha1, vascular endothelial growth factor, a disintegrin and metallopeptidase domain 33, scatter factor/hepatocyte growth factor, tissue inhibitor of matrix metalloproteinase-2, fibronectin, and collagen 3alpha1) decreased in small airways in association with FEV(1). In contrast, 8/12 genes (early growth response factor 1, MMP1, MMP9, MMP10, plasminogen activator urokinase, plasminogen activator urokinase receptor, tumornecrosis factor, and IL13) increased and 4/12 (MMP2, tissue inhibitor of matrix metalloproteinase-1, collagen 1alpha1, and transforming growth factor-beta3) decreased in the surrounding lung tissue in association with progression of COPD. CONCLUSIONS: The progression of COPD is associated with the differential expression of a cluster of genes that favor the degradation of the tissue surrounding the small conducting airways.
Authors: Sally Chappell; Leslie Daly; Kevin Morgan; Tamar Guetta Baranes; Josep Roca; Roberto Rabinovich; Ann Millar; Seamas C Donnelly; Vera Keatings; William MacNee; Jan Stolk; Pieter S Hiemstra; Massimo Miniati; Simonetta Monti; Clare M O'Connor; Noor Kalsheker Journal: Am J Hum Genet Date: 2006-07 Impact factor: 11.025
Authors: Lily Ding; Kevin B Quinlan; W Mark Elliott; Mowafak Hamodat; Peter D Paré; James C Hogg; Shizu Hayashi Journal: COPD Date: 2004 Impact factor: 2.409
Authors: Soo Jung Cho; Min Jong Kang; Robert J Homer; Hye Ryun Kang; Xuchen Zhang; Patty J Lee; Jack A Elias; Chun Geun Lee Journal: J Biol Chem Date: 2006-01-26 Impact factor: 5.157
Authors: Dawn L Demeo; Thomas J Mariani; Christoph Lange; Sorachai Srisuma; Augusto A Litonjua; Juan C Celedon; Stephen L Lake; John J Reilly; Harold A Chapman; Brigham H Mecham; Kathleen J Haley; Jody S Sylvia; David Sparrow; Avrum E Spira; Jennifer Beane; Victor Pinto-Plata; Frank E Speizer; Steven D Shapiro; Scott T Weiss; Edwin K Silverman Journal: Am J Hum Genet Date: 2005-12-15 Impact factor: 11.025
Authors: Victor Pinto-Plata; John Toso; Kwan Lee; Daniel Park; John Bilello; Hana Mullerova; Mary M De Souza; Rupert Vessey; Bartolome Celli Journal: Thorax Date: 2007-03-13 Impact factor: 9.139
Authors: Stephen I Rennard; Charles Fogarty; Steven Kelsen; William Long; Joe Ramsdell; James Allison; Donald Mahler; Constantine Saadeh; Thomas Siler; Phillip Snell; Phillip Korenblat; William Smith; Mitchell Kaye; Michael Mandel; Charles Andrews; Rachakonda Prabhu; James F Donohue; Rosemary Watt; Kim Hung Lo; Rozsa Schlenker-Herceg; Elliot S Barnathan; John Murray Journal: Am J Respir Crit Care Med Date: 2007-02-08 Impact factor: 21.405
Authors: Margot M E Gosman; H Marike Boezen; Cleo C van Diemen; Jiska B Snoeck-Stroband; Thérèse S Lapperre; Pieter S Hiemstra; Nick H T Ten Hacken; Jan Stolk; Dirkje S Postma Journal: Thorax Date: 2006-11-07 Impact factor: 9.139
Authors: Klaus F Rabe; Suzanne Hurd; Antonio Anzueto; Peter J Barnes; Sonia A Buist; Peter Calverley; Yoshinosuke Fukuchi; Christine Jenkins; Roberto Rodriguez-Roisin; Chris van Weel; Jan Zielinski Journal: Am J Respir Crit Care Med Date: 2007-05-16 Impact factor: 21.405
Authors: Thomas N Wight; Charles W Frevert; Jason S Debley; Stephen R Reeves; William C Parks; Steven F Ziegler Journal: Cell Immunol Date: 2016-12-23 Impact factor: 4.868
Authors: Fernando J Martinez; MeiLan K Han; James P Allinson; R Graham Barr; Richard C Boucher; Peter M A Calverley; Bartolome R Celli; Stephanie A Christenson; Ronald G Crystal; Malin Fagerås; Christine M Freeman; Lars Groenke; Eric A Hoffman; Mehmet Kesimer; Kostantinos Kostikas; Robert Paine; Shahin Rafii; Stephen I Rennard; Leopoldo N Segal; Renat Shaykhiev; Christopher Stevenson; Ruth Tal-Singer; Jørgen Vestbo; Prescott G Woodruff; Jeffrey L Curtis; Jadwiga A Wedzicha Journal: Am J Respir Crit Care Med Date: 2018-06-15 Impact factor: 21.405
Authors: Marc A Sze; Pedro A Dimitriu; Masaru Suzuki; John E McDonough; Josh D Campbell; John F Brothers; John R Erb-Downward; Gary B Huffnagle; Shizu Hayashi; W Mark Elliott; Joel Cooper; Don D Sin; Marc E Lenburg; Avrum Spira; William W Mohn; James C Hogg Journal: Am J Respir Crit Care Med Date: 2015-08-15 Impact factor: 21.405
Authors: Anne H Agler; Ronald G Crystal; Jason G Mezey; Jennifer Fuller; Chuan Gao; Joyanna G Hansen; Patricia A Cassano Journal: COPD Date: 2013-08 Impact factor: 2.409